Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 8 |
NetGPI | no | yes: 0, no: 8 |
Related structures:
AlphaFold database: E9AQD0
Term | Name | Level | Count |
---|---|---|---|
GO:0003824 | catalytic activity | 1 | 4 |
GO:0005488 | binding | 1 | 4 |
GO:0016491 | oxidoreductase activity | 2 | 4 |
GO:0043167 | ion binding | 2 | 4 |
GO:0043169 | cation binding | 3 | 4 |
GO:0046872 | metal ion binding | 4 | 4 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 154 | 158 | PF00656 | 0.657 |
CLV_C14_Caspase3-7 | 255 | 259 | PF00656 | 0.498 |
CLV_NRD_NRD_1 | 230 | 232 | PF00675 | 0.502 |
CLV_NRD_NRD_1 | 239 | 241 | PF00675 | 0.645 |
CLV_NRD_NRD_1 | 45 | 47 | PF00675 | 0.639 |
CLV_NRD_NRD_1 | 53 | 55 | PF00675 | 0.549 |
CLV_PCSK_FUR_1 | 228 | 232 | PF00082 | 0.537 |
CLV_PCSK_KEX2_1 | 230 | 232 | PF00082 | 0.502 |
CLV_PCSK_KEX2_1 | 239 | 241 | PF00082 | 0.645 |
CLV_PCSK_KEX2_1 | 282 | 284 | PF00082 | 0.569 |
CLV_PCSK_KEX2_1 | 44 | 46 | PF00082 | 0.618 |
CLV_PCSK_KEX2_1 | 53 | 55 | PF00082 | 0.551 |
CLV_PCSK_PC1ET2_1 | 282 | 284 | PF00082 | 0.569 |
CLV_PCSK_PC7_1 | 40 | 46 | PF00082 | 0.533 |
DEG_Nend_UBRbox_1 | 1 | 4 | PF02207 | 0.500 |
DOC_CKS1_1 | 159 | 164 | PF01111 | 0.598 |
DOC_CKS1_1 | 9 | 14 | PF01111 | 0.490 |
DOC_CYCLIN_yCln2_LP_2 | 9 | 15 | PF00134 | 0.484 |
DOC_MAPK_gen_1 | 53 | 61 | PF00069 | 0.453 |
DOC_MAPK_MEF2A_6 | 269 | 276 | PF00069 | 0.411 |
DOC_MAPK_MEF2A_6 | 53 | 61 | PF00069 | 0.456 |
DOC_MAPK_NFAT4_5 | 54 | 62 | PF00069 | 0.532 |
DOC_SPAK_OSR1_1 | 269 | 273 | PF12202 | 0.499 |
DOC_USP7_MATH_1 | 100 | 104 | PF00917 | 0.500 |
DOC_USP7_MATH_1 | 126 | 130 | PF00917 | 0.531 |
DOC_USP7_MATH_1 | 246 | 250 | PF00917 | 0.508 |
DOC_WW_Pin1_4 | 158 | 163 | PF00397 | 0.603 |
DOC_WW_Pin1_4 | 173 | 178 | PF00397 | 0.744 |
DOC_WW_Pin1_4 | 234 | 239 | PF00397 | 0.684 |
DOC_WW_Pin1_4 | 242 | 247 | PF00397 | 0.722 |
DOC_WW_Pin1_4 | 296 | 301 | PF00397 | 0.717 |
DOC_WW_Pin1_4 | 34 | 39 | PF00397 | 0.523 |
DOC_WW_Pin1_4 | 8 | 13 | PF00397 | 0.581 |
LIG_14-3-3_CanoR_1 | 116 | 120 | PF00244 | 0.444 |
LIG_14-3-3_CanoR_1 | 24 | 30 | PF00244 | 0.301 |
LIG_BRCT_BRCA1_1 | 264 | 268 | PF00533 | 0.663 |
LIG_EVH1_2 | 292 | 296 | PF00568 | 0.466 |
LIG_FHA_1 | 139 | 145 | PF00498 | 0.411 |
LIG_FHA_1 | 154 | 160 | PF00498 | 0.526 |
LIG_FHA_1 | 169 | 175 | PF00498 | 0.668 |
LIG_FHA_1 | 4 | 10 | PF00498 | 0.490 |
LIG_FHA_2 | 9 | 15 | PF00498 | 0.566 |
LIG_LIR_Gen_1 | 69 | 78 | PF02991 | 0.466 |
LIG_LIR_Nem_3 | 69 | 74 | PF02991 | 0.492 |
LIG_PDZ_Class_1 | 299 | 304 | PF00595 | 0.684 |
LIG_SH2_CRK | 71 | 75 | PF00017 | 0.423 |
LIG_SH2_STAP1 | 285 | 289 | PF00017 | 0.455 |
LIG_SH2_STAP1 | 92 | 96 | PF00017 | 0.511 |
LIG_SH3_2 | 278 | 283 | PF14604 | 0.340 |
LIG_SH3_3 | 156 | 162 | PF00018 | 0.639 |
LIG_SH3_3 | 171 | 177 | PF00018 | 0.671 |
LIG_SH3_3 | 275 | 281 | PF00018 | 0.333 |
LIG_SH3_3 | 297 | 303 | PF00018 | 0.546 |
LIG_SH3_3 | 35 | 41 | PF00018 | 0.585 |
MOD_CDC14_SPxK_1 | 37 | 40 | PF00782 | 0.503 |
MOD_CDK_SPK_2 | 234 | 239 | PF00069 | 0.599 |
MOD_CDK_SPxK_1 | 234 | 240 | PF00069 | 0.548 |
MOD_CDK_SPxK_1 | 34 | 40 | PF00069 | 0.546 |
MOD_CK1_1 | 176 | 182 | PF00069 | 0.764 |
MOD_CK1_1 | 295 | 301 | PF00069 | 0.665 |
MOD_CK1_1 | 33 | 39 | PF00069 | 0.543 |
MOD_CK2_1 | 8 | 14 | PF00069 | 0.526 |
MOD_DYRK1A_RPxSP_1 | 244 | 248 | PF00069 | 0.508 |
MOD_GlcNHglycan | 103 | 106 | PF01048 | 0.535 |
MOD_GlcNHglycan | 128 | 131 | PF01048 | 0.519 |
MOD_GlcNHglycan | 146 | 149 | PF01048 | 0.314 |
MOD_GlcNHglycan | 217 | 220 | PF01048 | 0.553 |
MOD_GlcNHglycan | 248 | 251 | PF01048 | 0.510 |
MOD_GlcNHglycan | 32 | 35 | PF01048 | 0.625 |
MOD_GSK3_1 | 173 | 180 | PF00069 | 0.807 |
MOD_GSK3_1 | 242 | 249 | PF00069 | 0.625 |
MOD_GSK3_1 | 258 | 265 | PF00069 | 0.751 |
MOD_GSK3_1 | 28 | 35 | PF00069 | 0.538 |
MOD_GSK3_1 | 292 | 299 | PF00069 | 0.676 |
MOD_NEK2_1 | 144 | 149 | PF00069 | 0.450 |
MOD_NEK2_1 | 151 | 156 | PF00069 | 0.454 |
MOD_NEK2_1 | 3 | 8 | PF00069 | 0.290 |
MOD_PKA_2 | 115 | 121 | PF00069 | 0.524 |
MOD_Plk_1 | 86 | 92 | PF00069 | 0.355 |
MOD_Plk_4 | 115 | 121 | PF00069 | 0.524 |
MOD_Plk_4 | 25 | 31 | PF00069 | 0.556 |
MOD_Plk_4 | 66 | 72 | PF00069 | 0.511 |
MOD_ProDKin_1 | 158 | 164 | PF00069 | 0.601 |
MOD_ProDKin_1 | 173 | 179 | PF00069 | 0.744 |
MOD_ProDKin_1 | 234 | 240 | PF00069 | 0.692 |
MOD_ProDKin_1 | 242 | 248 | PF00069 | 0.724 |
MOD_ProDKin_1 | 296 | 302 | PF00069 | 0.717 |
MOD_ProDKin_1 | 34 | 40 | PF00069 | 0.522 |
MOD_ProDKin_1 | 8 | 14 | PF00069 | 0.579 |
TRG_ENDOCYTIC_2 | 71 | 74 | PF00928 | 0.499 |
TRG_ER_diArg_1 | 228 | 231 | PF00400 | 0.535 |
TRG_ER_diArg_1 | 238 | 240 | PF00400 | 0.699 |
TRG_ER_diArg_1 | 43 | 46 | PF00400 | 0.574 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1ILL8 | Leptomonas seymouri | 53% | 90% |
A0A3R7RI28 | Trypanosoma rangeli | 32% | 100% |
A0A3S7WTT4 | Leishmania donovani | 87% | 100% |
A4H8A3 | Leishmania braziliensis | 74% | 100% |
A4HWM3 | Leishmania infantum | 87% | 100% |
C9ZXR4 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 34% | 100% |
Q4QF45 | Leishmania major | 84% | 100% |